Drug-target residence time and its implications for lead optimization
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromolecules by low-molecular-mass drugs. The binding of drugs to their macromolecular targets is therefore seen as paramount for pharmacological activity. In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC(50) or K(d). This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex. We describe the potential advantages of long residence time in terms of duration of pharmacological effect and target selectivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The translation between slow inhibitor binding kinetics and sustained pharmacodynamic modulation has been studied for a numberoftarget classes (58).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [58]
In the citing paper
“Furthermore, the targets of infectious diseases usually have high replication rates, while covalent inhibitors tend to have long residence times making them less effective in this area [128].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [128]
In the citing paper
“Furthermore, longer residence times of drugs with their targets, as a result of slower off-rates, is a useful mechanism to extend in-vivo efficacy (59–61).”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [59]
Citations
Cites
Catalysis in chemistry and enzymology
Jencks, W. P. (1969) · Medical Entomology and Zoology · Cited by 3,217
Structure and Mechanism in Protein Science
Fersht, A. (1998) · Cited by 1,882
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,122
Copeland, R. A. (2005) · PubMed · Cited by 1,092
Self-citationLiang, J., Woodward, C., & Edelsbrunner, H. (1998) · Protein Science · doi:10.1002/pro.5560070905 · Cited by 1,057
Enzymes: a practical introduction to structure, mechanism, and data analysis
(2001) · Choice Reviews Online · doi:10.5860/choice.38-3881 · Cited by 1,056
Optical biosensors in drug discovery
Cooper, M. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd838 · Cited by 1,015
Oppenheimer, N. J., & James, T. L. (1989) · Academic Press eBooks · Cited by 820
Rusnak, D. W., Lackey, K. E., Affleck, K., Wood, E. R., Alligood, K. J., Rhodes, N., Keith, B. R., Murray, D. M., Knight, W. B., Mullin, R. J., et al. (2001) · PubMed · Cited by 728
Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis
Copeland, R. A. (2000) · Wiley eBooks · doi:10.1002/0471220639 · Cited by 726
Self-citation
Cited by
Items 901–1,000 of 1,003
Ligand-receptor binding kinetics in drug design
Borisov, D. V., & Veselovsky, A. V. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206601042 · Cited by 12
Xue, W., Zhu, F., Yang, F., Yang, J., Zhang, Z., Tu, G., & Yao, X. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210708090123 · Cited by 11
RBx 6198: A novel α1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia
Nanda, K., Naruganahalli, K. S., Gupta, S. K. D., Malhotra, S., Tiwari, A. K., Hegde, L. G., Jain, S. R., Sinha, N., Gupta, J. B., Chugh, A., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.02.026 · Cited by 11
Nishiyama, K., & Hirai, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.009 · Cited by 11
Wang, C., Wang, X., Xu, X., Liu, B., Xu, X., Sun, L., Li, H., & Zhang, J. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.12.026 · Cited by 11
Kitano, Y., Kai, K., Yamamura, N., Yoshiba, S., & Kuroha, M. (2019) · Folia Pharmacologica Japonica · doi:10.1254/fpj.154.352 · Cited by 11
Akher, F. B., Farrokhzadeh, A., Ravenscroft, N., & Kuttel, M. M. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c03440 · Cited by 11
Vauquelin, G., & Maes, D. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.847 · Cited by 12
Discovery and Development of Telaprevir
Grillot, A., Farmer, L. J., Rao, B. G., Taylor, W. P., Weisberg, I. S., Jacobson, I. M., Perni, R. B., & Kwong, A. D. (2011) · Wiley eBooks · doi:10.1002/9780470929353.ch15 · Cited by 11
Mason, J. L., Spais, C. M., Husten, J., Prouty, E. W., Albom, M. S., Meyer, S. L., Ator, M. A., & Angeles, T. S. (2012) · Assay and Drug Development Technologies · doi:10.1089/adt.2012.453 · Cited by 11
Li, Q., Deng, X., Xu, Y., & Dong, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00412 · Cited by 10
ModBind, a Rapid Simulation-Based Predictor of Ligand Binding and Off-Rates
Sinko, W., Mertz, B., Shimizu, T., Takahashi, T., Terada, Y., & Kimura, S. R. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01805 · Cited by 11
Bhanja, K., & Patra, N. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c07651 · Cited by 12
Overcoming Effects of Heterogeneous Binding on BLI Analysis
Sherer, N., & Cho, J. (2025) · ACS Omega · doi:10.1021/acsomega.5c03942 · Cited by 10
Krönke, T., Trommer, J., Ullrich, M., Laube, M., Löser, R., Kretzschmar, J., Urbanová, M., Stadlbauer, S., Brandt, F., Platzek, I., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02371 · Cited by 10
A “Cell Space Station” for Spatiotemporal Molecular Manipulation of Immune Checkpoint
Li, L., Li, M., Wang, M., Zhang, L., Yu, Y., Zhang, J., Ma, B., & Wang, W. (2022) · ACS Nano · doi:10.1021/acsnano.2c05483 · Cited by 10
15 Years of molecular simulation of drug-binding kinetics
Wong, C. F. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2264770 · Cited by 12
A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Niazi, S. K. (2023) · Pharmaceuticals · doi:10.3390/ph16111556 · Cited by 13
Dodaro, A., Pavan, M., Menin, S., Salmaso, V., Sturlese, M., & Moro, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1294543 · Cited by 10
The Intricacies of Renal Phosphate Reabsorption—An Overview
Walker, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094684 · Cited by 17
Can biochemistry drive drug discovery beyond simple potency measurements?
Chêne, P. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.022 · Cited by 11
Alonso, J. A., Andrés, M., Bravo, M., Buil, M. A., Calbet, M., Castro, J., Eastwood, P. R., Esteve, C., Ferrer, M., Forns, P., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.08.028 · Cited by 10
Hau, J. C., Fontana, P., Zimmermann, C., Pover, A. D., Erdmann, D., & Chêne, P. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111399573 · Cited by 12
Miyahisa, I., Suzuki, H., Mizukami, A., Tanaka, Y., Ono, M., Hixon, M. S., & Matsui, J. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00241 · Cited by 10
Label-free NMR-based dissociation kinetics determination
Trigo‐Mouriño, P., Griesinger, C., & Lee, D. (2017) · Journal of Biomolecular NMR · doi:10.1007/s10858-017-0150-5 · Cited by 10
Zuckerman, D. M., & Russo, J. D. (2021) · American Journal of Physics · doi:10.1119/10.0005603 · Cited by 10
Tabuchi, Y., Watanabe, T., Katsuki, R., Ito, Y., & Taki, M. (2021) · Chemical Communications · doi:10.1039/d1cc01773j · Cited by 10
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB 1 R)
Mach, L., Omran, A., Bouma, J., Radetzki, S., Sykes, D. A., Guba, W., Li, X., Höffelmeyer, C., Hentsch, A., Gazzi, T., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00465 · Cited by 13
How does a hydrocarbon staple affect peptide hydrophobicity?
Sim, A. Y. L., & Verma, C. S. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.23859 · Cited by 11
Optimizing glucokinase activator binding kinetics to lower in vivo hypoglycemia risk
Borzilleri, K. A., Pfefferkorn, J. A., Guzmán-Pérez, A., Liu, S., Qiu, X., Chrunyk, B. A., Song, X., Tu, M., Filipski, K. J., Aiello, R. J., et al. (2014) · MedChemComm · doi:10.1039/c4md00027g · Cited by 10
Bárta, P., Andersson, K., Trejtnar, F., & Buijs, J. (2014) · Journal of Analytical Oncology · doi:10.6000/1927-7229.2014.03.02.4 · Cited by 13
Ke, S., Wright, J. C., & Kwon, G. S. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700182t · Cited by 10
Molecular simulation of drug-binding kinetics
Wong, C. F. (2014) · Molecular Simulation · doi:10.1080/08927022.2014.890722 · Cited by 10
Aranda-Tavío, H., Recio, C., Martín-Acosta, P., Guerra-Rodríguez, M., Brito‐Casillas, Y., Blanco, R. E., Junco, V., León, J., Montero, J. C., Gandullo‐Sánchez, L., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112330 · Cited by 10
Shimizu, Y., Ishii, T., Ogawa, K., Sasaki, S., Matsui, H., & Nakayama, M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.062 · Cited by 10
Kinetically selective and potent inhibitors of HDAC8
Schweipert, M., Jänsch, N., Sugiarto, W. O., & Meyer‐Almes, F. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0363 · Cited by 10
Chemoselective Reagents for the Traceless Bioreversible Modification of Native Proteins
Petri, Y. D., FitzGerald, F. G., & Raines, R. T. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00338 · Cited by 10
Li, M., Thapa, P., Rajaputra, P., Bio, M., Peer, C. J., Figg, W. D., You, Y., & Woo, S. (2017) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9543-z · Cited by 10
A Pharmacological perspective on the temporal properties of sweeteners
Servant, G., & Kenakin, T. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107211 · Cited by 9
Coricello, A., Chiaravalle, A. L., Musgaard, M., Tehan, B. G., Elisi, G. M., & Bottegoni, G. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00601 · Cited by 9
Machine learning for predicting drug–drug interactions: Graph neural networks and beyond
Petschner, P., Nguyen, A. D., Nguyen, C. H., & Mamitsuka, H. (2025) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2025.100551 · Cited by 12
Glen, R. C., Cole, J. C., & Stewart, J. J. P. (2025) · Journal of Molecular Modeling · doi:10.1007/s00894-025-06423-7 · Cited by 10
He, Y., Liao, T., Wang, X., Xiao, Q. H., Wang, H., He, R. R., Zhao, C., Tian, X., Gao, Q., & Hao, L. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108846 · Cited by 11
Wang, X., Phan, M. M., Li, J., Gill, H. S., Williams, S. P., Gupta, N., Quarmby, V. E., & Yang, J. (2020) · Antibodies · doi:10.3390/antib9020007 · Cited by 9
Cifone, M. T., He, Y., Basu, R., Wang, N., Davoodi, S., Spagnuolo, L. A., Si, Y., Daryaee, T., Stivala, C. E., Walker, S. G., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01380 · Cited by 9
Zingale, G. A., Distefano, A., & Grasso, G. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230116162646 · Cited by 9
Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human Kinases
Wang, L., Bohmer, M. J., Wang, J., Nardella, F., Calla, J., de Souza, M. L., Schindler, K. A., Montejo, L., Mittal, N., Rocamora, F., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02046 · Cited by 9
Host–Guest Binding Free Energies à la Carte: An Automated OneOPES Protocol
Martinez, P. F., Rizzi, V., Aureli, S., & Gervasio, F. L. (2024) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c01112 · Cited by 12
Jin, C., Zhou, X., Xu, M., Okanishi, H., Ohgaki, R., & Kanai, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-87522-6 · Cited by 13
de Broglie Swapping Metadynamics for Quantum and Classical Sampling
Nava, M., Quhe, R., Palazzesi, F., Tiwary, P., & Parrinello, M. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00818 · Cited by 9
Dynamics of ligand binding to GPCR: Residence time of melanocortins and its modulation
Rinken, A., Veikšina, S., & Kopanchuk, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.030 · Cited by 9
Surface Binding Energy Landscapes Affect Phosphodiesterase Isoform-Specific Inhibitor Selectivity
Liu, Q., Herrmann, A., & Huang, Q. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.11.009 · Cited by 9
Lee, S., Son, W. S., Yang, H. B., Rajasekaran, N., Kim, S.-S., Hong, S., Choi, J., Choi, J. Y., Song, K., & Shin, Y. K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01568 · Cited by 10
Fluxes for Unraveling Complex Binding Mechanisms
Vauquelin, G., Maes, D., & Swinney, D. C. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.10.003 · Cited by 9
Ludwig, J., Smith, J. K., & Pfaendtner, J. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00221 · Cited by 10
Rao, B. G., Murcko, M. A., Tebbe, M. J., & Kwong, A. D. (2015) · Wiley eBooks · doi:10.1002/9783527678433.ch10 · Cited by 9
Are Label-Free Investigations the Best Approach to Drug Discovery?
Ye, F. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.84 · Cited by 9
Yiu, K.-W., Lee, C.-K., Kwok, K. C., & Cheung, N. H. (2014) · Environmental Science & Technology · doi:10.1021/es503801c · Cited by 9
Focusing on probe-modified peptides: a quick and effective method for target identification
Sun, H., Ren, Y., Hou, W., Li, L., Zeng, F., Li, S., Ma, Y., Liu, X., Chen, S., & Zhang, Z. (2016) · Chemical Communications · doi:10.1039/c6cc04030f · Cited by 9
Simard, J. R., & Rauh, D. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-397918-6.00006-9 · Cited by 9
Conner, J., Poole, D. P., Jörg, M., & Veldhuis, N. A. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0327 · Cited by 9
Eltschkner, S., Kehrein, J., Le, T. A., Davoodi, S., Merget, B., Basak, S., Weinrich, J. D., Schiebel, J., Tonge, P. J., Engels, B., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00437 · Cited by 9
Molecular Aspects of Histamine Receptors
Mocking, T. A. M., Bosma, R., Rahman, S. N., Verweij, E. W. E., McNaught-Flores, D. A., Vischer, H. F., & Leurs, R. (2016) · The Receptors · doi:10.1007/978-3-319-40308-3_1 · Cited by 13
Stabilizing HDAC11 with SAHA to assay slow-binding benzamide inhibitors
Tian, Y., Lv, W., Li, X., Wang, C., Wang, D., Wang, P. G., Jin, J., & Shen, J. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.004 · Cited by 9
Wang, H., Liu, L., Lü, Y., Pan, P., Hooker, J. M., Fowler, J. S., & Tonge, P. J. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.019 · Cited by 9
Li, L., Zhang, J., Li, Y., Huang, C. Y., Xu, J., Zhao, Y., & Zhang, P. (2024) · Biosensors · doi:10.3390/bios14110524 · Cited by 8
Huang, C. Y., Zhang, J., Liu, Z., Xu, J., Zhao, Y., & Zhang, P. (2024) · Biosensors · doi:10.3390/bios14110537 · Cited by 8
Kaplan, R., Zhao, Y., Tsai, J. C., Dickinson, B., Swanson, T. E., Foster, K., & Bedian, V. (2025) · mAbs · doi:10.1080/19420862.2025.2585616 · Cited by 8
Advances in BRET probes for intracellular target engagement studies
Capener, J. L., Schwalm, M. P., Vasta, J. D., Michaud, A., Teske, K. A., Marsiglia, W. M., Huber, K., Dar, A. C., Knapp, S., Axtman, A. D., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02103-y · Cited by 9
Understanding drug-target residence time and the implications on drug discovery
Liu, H., Zhong, H., & Guo, D. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2619070 · Cited by 11
Hussein, M. A., & Munirathinam, G. (2026) · Cancers · doi:10.3390/cancers18050719 · Cited by 10
Eberle, S. A., & Gustavsson, M. (2022) · Cells · doi:10.3390/cells11081317 · Cited by 12
Falkenstern, L., Georgi, V., Bunse, S., Badock, V., Husemann, M., Roehn, U., Stellfeld, T., Fitzgerald, M. E., Ferrara, S. J., Stöckigt, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50964-x · Cited by 9
Kinetic Binding Mechanisms: Their Contribution to an Optimal Therapeutic Index
Swinney, D. C. (2011) · Wiley eBooks · doi:10.1002/9780470979129.ch19 · Cited by 8
Aliskiren displays long-lasting interactions with human renin
Gossas, T., Vrang, L., Henderson, I. M., Sedig, S., Sahlberg, C., Lindström, E., & Danielson, U. H. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0718-7 · Cited by 8
A comparison report of three advanced methods for drug-cyclodextrin interaction measurements
Singh, V., He, Y., Wang, C., Xu, J., Xu, X., Li, H., Singh, P., York, P., Sun, L., & Zhang, J. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.11.037 · Cited by 8
Nava, M., Palazzesi, F., Perego, C., & Parrinello, M. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6b00691 · Cited by 8
de Lucio, H., Toro-Londoño, M., Camarasa, M., Velázquez, S., Gago, F., & Jiménez-Ruı́z, A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15250 · Cited by 8
Ginn, J. D., Jiang, X., Sun, S., Michino, M., Huggins, D. J., Mbambo, Z., Jansen, R. S., Rhee, K. Y., Arango, N., Lima, C. D., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00788 · Cited by 8
Labenski, M., Bateman, L. A., Voortman, L., Giammo, G., Cantin, S. M., Qiao, L., & Corin, A. F. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00422 · Cited by 8
Galaxy workflows for fragment-based virtual screening: a case study on the SARS-CoV-2 main protease
Bray, S. A., Dudgeon, T., Skyner, R., Backofen, R., Grüning, B. A., & von Delft, F. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00588-6 · Cited by 8
Fragment‐Based De Novo Design Reveals a Small‐Molecule Inhibitor of Helicobacter Pylori HtrA
Perna, A. M., Rodrigues, T., Schmidt, T. P., Böhm, M., Stutz, K., Reker, D., Pfeiffer, B., Altmann, K., Backert, S., Weßler, S., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201504035 · Cited by 8
Batchelder, H. R., Zandi, T. A., Kaushik, A., Naik, A., Story‐Roller, E., Maggioncalda, E. C., Lamichhane, G., Nuermberger, E. L., & Townsend, C. A. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00229 · Cited by 8
Srinivasan, B., Weidinger, J. D. F., Zhai, X., Lemercier, G., Ikeda, T., Brewer, M., Zhang, B., Heyse, S., Wingfield, J. M., & Steigele, S. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2022.09.003 · Cited by 8
Fuchs, N. S., Meta, M., Lantzberg, B., Bros, M., Kuan, S. L., Weil, T., & Schirmeister, T. (2023) · ChemMedChem · doi:10.1002/cmdc.202300160 · Cited by 8
Water Migration through Enzyme Tunnels Is Sensitive to the Choice of Explicit Water Model
Thirunavukarasu, A. S., Szleper, K., Tanriver, G., Marchlewski, I., Mitusińska, K., Góra, A., & Brezovský, J. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01177 · Cited by 8
Vilums, M., Zweemer, A. J. M., Dilanchian, A., van Veldhoven, J. P. D., de Vries, H., Brussee, J., Saunders, J., Stamos, D. P., Heitman, L. H., & IJzerman, A. P. (2015) · ChemMedChem · doi:10.1002/cmdc.201500058 · Cited by 8
Schmitt, S., Höfner, G. C., & Wanner, K. T. (2014) · Analytical Chemistry · doi:10.1021/ac501366r · Cited by 8
Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist
Bandholtz, S., Erdmann, S., von Hacht, J. L., Exner, S., Krause, G., Kleinau, G., & Grötzinger, C. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00164 · Cited by 8
de Witte, W. E. A., Rottschäfer, V., Danhof, M., van der Graaf, P. H., Peletier, L. A., & de Lange, E. C. M. (2018) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-018-9593-x · Cited by 8
Quantification of In Vivo Target Engagement Using Microfluidic Activity-Based Protein Profiling
Reardon, H. T., Herbst-Graham, R. A., Henry, C. L., Herbst, D. M., Ngo, N., Cisar, J. S., Weber, O. D., Niphakis, M. J., & O’Neill, G. P. (2019) · SLAS TECHNOLOGY · doi:10.1177/2472630319852303 · Cited by 8
Chaudhry, C., Tebben, A. J., Tokarski, J. S., Borzilleri, R. M., Pitts, W. J., Lippy, J., & Zhang, L. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.018 · Cited by 9
Estimation of binding rates and affinities from multiensemble Markov models and ligand decoupling
Ge, Y., & Voelz, V. A. (2022) · The Journal of Chemical Physics · doi:10.1063/5.0088024 · Cited by 10
Milestoning simulation of ligand dissociation from the glycogen synthase kinase 3β
Rathnayake, S., Narayan, B., Elber, R., & Wong, C. F. (2022) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26423 · Cited by 8
Copeland, R. A. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673025.ch8 · Cited by 8
Self-citationComputational analysis and predictive modeling of polymorph descriptors
Lee, Y., Jana, S., Acharya, G., & Lee, C. H. (2013) · Chemistry Central Journal · doi:10.1186/1752-153x-7-23 · Cited by 8
Sarma, B. K., Liu, X., & Kodadek, T. J. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.047 · Cited by 8
Targeting Kinetoplastid and Apicomplexan Thymidylate Biosynthesis as an Antiprotozoal Strategy
Valente, M., Vidal, A. E., & González‐Pacanowska, D. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180926154329 · Cited by 8
Wennerberg, M., Balendran, A., Clapham, J. C., & Vauquelin, G. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00756.x · Cited by 8
Bravo, E., Li, Y., Lin, D. Y.-W., Srinivasan, B., Barone, M., Li, S. X., DelloRusso, F., Rahiyanath, A. S., Corrionero, A., Alfonso, P., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c07063 · Cited by 7
Metadata
- Authors
- Copeland, R. A., Pompliano, D. L., & Meek, T. D.
- Affiliations
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Copeland, Robert A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-08-04
- Volume
- 5
- Issue
- 9
- Pages
- 730-739
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2016408686
- Semantic Scholar
- 362824beb2008831aa65b4eb774e5c8703ff9c71
- Cited by
- 1,464
- References
- 46
- Citations by year
- 2026: 83 · 2025: 64 · 2024: 78 · 2023: 79 · 2022: 81 · 2021: 76 · 2020: 83 · 2019: 88 · 2018: 102 · 2017: 104 · 2016: 96 · 2015: 120 · 2014: 74 · 2013: 88 · 2012: 65
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- drug-target residence time, lead optimization, drug selectivity, drug-target binding, binding affinity
- MeSH terms
- Binding, Competitive, Pharmaceutical Preparations, Humans, Kinetics, Ligands, Technology, Pharmaceutical, Drug Design, Drug Delivery Systems, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.